[Alpha Biz= Reporter Kim Jisun] Sam Chun Dang Pharm's share price plunged recently due to unfavorable rumors circulating in the market, suggesting a legal response to the distributor.
According to the Korea Exchange on the 4th, Sam Chun Dang Pharm closed at 111,400 won on the KOSDAQ market. The stock price plunged 20% in three trading days from KRW 140,700 on the 1st.
There is a rumor that spread in the market behind the plunge in Sam Chun Dang Pharm's stock price. It is a negative rumor related to the core valuation business, the Ilia biosimilar, and the sale of the largest shareholder.
The largest shareholder of Sam Chun Dang Pharm is Sohwa (30.7%). Yoon Dae-in, chairman of Samcheondang Pharmaceutical, holds 6.9%. The largest shareholder of unlisted companies is Chairman Yoon (72.22%).
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
